Cargando…
Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Royal College of Radiologists. Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382576/ https://www.ncbi.nlm.nih.gov/pubmed/32723485 http://dx.doi.org/10.1016/j.clon.2020.07.006 |
| _version_ | 1783563271439122432 |
|---|---|
| author | Earl, H.M. Hiller, L. Dunn, J. Macpherson, I. Rea, D. Hughes-Davies, L. McAdam, K. Hall, P. Mansi, J. Wheatley, D. Abraham, J.E. Caldas, C. Gasson, S. O'Riordan, E. Wilcox, M. Miles, D. Cameron, D.A. Wardley, A. |
| author_facet | Earl, H.M. Hiller, L. Dunn, J. Macpherson, I. Rea, D. Hughes-Davies, L. McAdam, K. Hall, P. Mansi, J. Wheatley, D. Abraham, J.E. Caldas, C. Gasson, S. O'Riordan, E. Wilcox, M. Miles, D. Cameron, D.A. Wardley, A. |
| author_sort | Earl, H.M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7382576 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | The Royal College of Radiologists. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73825762020-07-28 Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK Earl, H.M. Hiller, L. Dunn, J. Macpherson, I. Rea, D. Hughes-Davies, L. McAdam, K. Hall, P. Mansi, J. Wheatley, D. Abraham, J.E. Caldas, C. Gasson, S. O'Riordan, E. Wilcox, M. Miles, D. Cameron, D.A. Wardley, A. Clin Oncol (R Coll Radiol) Editorial The Royal College of Radiologists. Published by Elsevier Ltd. 2021-01 2020-07-25 /pmc/articles/PMC7382576/ /pubmed/32723485 http://dx.doi.org/10.1016/j.clon.2020.07.006 Text en © 2020 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Editorial Earl, H.M. Hiller, L. Dunn, J. Macpherson, I. Rea, D. Hughes-Davies, L. McAdam, K. Hall, P. Mansi, J. Wheatley, D. Abraham, J.E. Caldas, C. Gasson, S. O'Riordan, E. Wilcox, M. Miles, D. Cameron, D.A. Wardley, A. Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK |
| title | Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK |
| title_full | Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK |
| title_fullStr | Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK |
| title_full_unstemmed | Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK |
| title_short | Optimising the Duration of Adjuvant Trastuzumab in Early Breast Cancer in the UK |
| title_sort | optimising the duration of adjuvant trastuzumab in early breast cancer in the uk |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7382576/ https://www.ncbi.nlm.nih.gov/pubmed/32723485 http://dx.doi.org/10.1016/j.clon.2020.07.006 |
| work_keys_str_mv | AT earlhm optimisingthedurationofadjuvanttrastuzumabinearlybreastcancerintheuk AT hillerl optimisingthedurationofadjuvanttrastuzumabinearlybreastcancerintheuk AT dunnj optimisingthedurationofadjuvanttrastuzumabinearlybreastcancerintheuk AT macphersoni optimisingthedurationofadjuvanttrastuzumabinearlybreastcancerintheuk AT read optimisingthedurationofadjuvanttrastuzumabinearlybreastcancerintheuk AT hughesdaviesl optimisingthedurationofadjuvanttrastuzumabinearlybreastcancerintheuk AT mcadamk optimisingthedurationofadjuvanttrastuzumabinearlybreastcancerintheuk AT hallp optimisingthedurationofadjuvanttrastuzumabinearlybreastcancerintheuk AT mansij optimisingthedurationofadjuvanttrastuzumabinearlybreastcancerintheuk AT wheatleyd optimisingthedurationofadjuvanttrastuzumabinearlybreastcancerintheuk AT abrahamje optimisingthedurationofadjuvanttrastuzumabinearlybreastcancerintheuk AT caldasc optimisingthedurationofadjuvanttrastuzumabinearlybreastcancerintheuk AT gassons optimisingthedurationofadjuvanttrastuzumabinearlybreastcancerintheuk AT oriordane optimisingthedurationofadjuvanttrastuzumabinearlybreastcancerintheuk AT wilcoxm optimisingthedurationofadjuvanttrastuzumabinearlybreastcancerintheuk AT milesd optimisingthedurationofadjuvanttrastuzumabinearlybreastcancerintheuk AT cameronda optimisingthedurationofadjuvanttrastuzumabinearlybreastcancerintheuk AT wardleya optimisingthedurationofadjuvanttrastuzumabinearlybreastcancerintheuk |